Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recent Biotech Financings: Avila, Limerick Biopharma, Cognition Therapeutics, Oxigene

This article was originally published in The Pink Sheet Daily

Executive Summary

Is sunshine starting to break through for biotech financing? Cognition Therapeutics Series A Financing shows that funding for biotechs breaking into the disease-modifying arena of Alzheimer's is picking up; more financings from late July.

You may also be interested in...



Financings Of The Fortnight: Follow-On Fever

Does the recent rash of follow-on public offerings mean biotech IPOs are around the corner? Recent financings provide reason to think it's possible.

Financings Of The Fortnight: Follow-On Fever

Does the recent rash of follow-on public offerings mean biotech IPOs are around the corner? Recent financings provide reason to think it's possible.

Novartis Options Avila's Protein-Silencing

Deal signals growing role for corporate VC and acceptance of option structure .

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069771

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel